| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Regular Article |
a Department of Animal Science, University of Missouri-Columbia, Columbia, Missouri 65201
b BioTransplant Inc., Charlestown, Massachusetts 02129
ABSTRACT
Different factors are believed to influence the outcome of nuclear transfer (NT) experiments. Besides the cell cycle stage of both recipient cytoplast and donor karyoplast, the origin of the donor cells (embryonic, fetal, and adult) is of interest. We compared in vitro development of NT embryos derived from small serum-starved (G0) or small cycling (G1) porcine fetal fibroblast cells. Serum starvation did not have a positive effect on cleavage rate or the percentage of embryos that developed to the morula and blastocyst stages. Next, we investigated the development of porcine NT embryos derived from different transgenic clonal cell lines that had originated from the same fetus. When different clonal lines of fetal fibroblasts were fused to enucleated metaphase II oocytes, differences in fusion rates as well as in development to the morula and blastocyst stages were observed (P < 0.05). When oocytes derived from sow ovaries were used as recipient cytoplasts, significantly better cleavage (P = 0.03) and blastocyst formation (P < 0.014) was obtained when compared with oocytes derived from gilts. Our data indicate that not only different cell lines, but also different clones derived from one primary cell line, result in different development when used for NT. In addition, the use of sow oocytes as a cytoplast source also improves the efficiency of NT experiments.
developmental biology, early development, embryo, gamete biology, oocyte development
INTRODUCTION
Somatic cell nuclear transfer (NT) in mammalian species has developed and advanced in the last 5 yr and many associated factors have been the subject of investigation (reviewed in [1]). Live animals have been produced from mice [2], sheep [3, 4], goats [5], cattle [6, 7], and pigs [8, 9] using differentiated, embryo-derived fetal or adult cells. However, different efficiencies using different cell types are reported [2, 10]. NT technology was also successfully used to generate transgenic sheep and cattle [11, 12]. A major advance has now been achieved with the production of live transgenic sheep derived from fibroblasts that were genetically modified by homologous recombination [13]. This powerful technique is highly important for developing animal models for various diseases, providing organs for xenotransplantation [14], and many other applications [15, 16].
The subject of this study was to investigate the suitability of different transgenic clones of fetal fibroblasts for use in NT in pigs. One of the factors we discuss as influencing the efficiency of NT is the cell cycle stage of the donor cells. It has been claimed that the use of cells in presumptive G0 [4] or G1 [12] stage is mandatory for correct and complete reprogramming, and was investigated in this study for porcine fibroblast cells. Last, we purchased a limited number of sow-derived oocytes and investigated the feasibility of this cytoplast source for use in NT.
MATERIALS AND METHODS
Unless stated otherwise, all chemicals for this study were purchased from Sigma Chemical Company (St. Louis, MO).
Source of Oocytes, In Vitro Maturation, and Enucleation
Oocytes were aspirated from ovaries that had been obtained from an abattoir. Oocytes derived from gilts were matured in a defined protein-free medium (TCM199, supplemented with 0.1% polyvinyl alcohol, 0.1 mg/ml cysteine, 10 ng/ml epidermal growth factor [EGF], 0.91 mM Na-pyruvate, 3.05 mM D-glucose, 0.5 µg/ml FSH, 0.5 µg/ml LH, 75 µg/ml penicillin, and 50 µg/ml streptomycin [17]). Oocytes from sow ovaries were purchased from BOMED (Madison, WI); they were matured in TCM199-Hepes supplemented with 5 µg/ml insulin, 10 ng/ml EGF, 0.6 mM cysteine, 0.2 mM Na-pyruvate, 3 µg/ml FSH, 25 µg/ml gentamicin, and 10% porcine follicular fluid, and were shipped overnight in maturation medium. In a previous experiment, the development of parthenogenetically activated oocytes (from gilts) matured in both media was compared, and no difference was observed (unpublished data). In addition, there was no difference after in vitro fertilization and culture to the blastocyst stage [18]. For NT experiments, metaphase II (MII) oocytes of both sources were treated the same.
After 42–44 h of maturation, oocytes were freed of cumulus and corona cells by vigorous pipetting in the presence of 0.1% hyaluronidase. Oocytes with an intact plasma membrane were selected and kept in TCM199 supplemented with 4 mg/ml bovine serum albumin (TCM/BSA) until use. MII oocytes were enucleated in TCM/BSA supplemented with 7.5 µg/ml cytochalasin B. The first polar body and the surrounding cytoplasm was removed with the aid of a beveled pipette with an inner diameter of 
25–30 µm [19]. Enucleated oocytes were kept in TCM/BSA until NT.
Isolation, Transfection, and Preparation of Donor Cells
For experiment 1, primary cell cultures of porcine fibroblast cells were derived from fetuses on Day 28 of gestation. Each fetus was washed three times in Ca/Mg-free PBS. After the head and inner organs were removed, the remaining tissue was cut into pieces and digested in 0.1% trypsin/0.02% EDTA for 10 min at room temperature. The suspension, including clumps of tissue of each fetus, was washed twice in culture medium (Dulbecco modified Eagle medium supplemented with 15% fetal calf serum [FCS], 1 mM Na-pyruvate, 0.01 mM modified Eagle medium-nonessential amino acids, 2 mM L-glutamine, 103 units/ml penicillin, and 0.1 mg/ml streptomycin) and seeded individually onto 100-mm dishes. Cell culture was performed at 39°C in 5% CO2 in air and 100% humidity. Standard trypsinization was performed using 0.1% trypsin in 0.02% EDTA. At passage 7, small aliquots (2000 cells/vial) of cycling or serum-starved (0.5% FCS for 6 days) fibroblast cells were frozen.
For the remaining experiments, "fetal fibroblasts" were isolated from a male major histocompatibility complex-defined miniature swine fetus at Day 37 of gestation by collagenase digestion and brief trypsinization of minced carcasses. Dissociated cells were cultured for 4 days prior to electroporation with a promoter trap vector containing the coding region of the aminoglycoside phosphotransferase gene downstream of the human immunoglobulin internal ribosome entry site, BiP [20]. Following transfection, cells were plated in 96-well clusters at a density of 1.5 x 104 trypan blue-excluding cells/well and were selected with 100 µg/ml G418 beginning 24 h post-transfection. After the selection period, clones were obtained in 1.3% of the wells plated, and were expanded with selection through an estimated total of 20–23 population doublings ex vivo prior to cryopreservation in small aliquots. There was no obvious difference in morphological characteristics or the proliferation intensity between the cell lines.
Prior to NT, cells were thawed at 37°C, and 200 µl FCS was added. The suspension was kept at room temperature for 45–60 min. Subsequently, 800 µl TCM/BSA was added and the cells were pelleted at 400 x g for 4 min. Fibroblast cells were resuspended in 15–20 µl of medium for direct use in NT.
Nuclear Transfer
Manipulations were carried out in TCM/BSA. Cells were selected according to their size and shape (small cells with a smooth membrane [21]). A single cell was then transferred into the perivitelline space with the same pipette that was used for enucleation. Care was taken to ensure a close contact between the cytoplasm and the donor cell. Reconstructed embryos were fused and simultaneously activated. Cytoplast-fibroblast complexes were placed between two electrodes (1 mm apart) overlayed with fusion medium (0.3 M mannitol, 1 mM CaCl2, 0.1 mM MgCl2, 0.5 mM Hepes) and aligned manually. Fusion/activation was achieved with two pulses of 2.6 kV/cm for 30 µsec measured by the BTX optimizer (Biotechnology and Experimental Research, San Diego, CA) 48 h after the onset of maturation. Embryos were kept in TCM/BSA for another hour before fusion was evaluated. Fused embryos were cultured in 500 µl NCSU23 [22], supplemented with 4 mg/ml BSA overlayed with mineral oil. On Day 2, the surviving embryos (intact plasma membrane) were selected and cultured for another 5 days in 50 µl of the same medium under mineral oil (10–20 embryos/drop). At the end of the culture period (Day 7) embryos were evaluated morphologically (blastocyst rate) and subsequently stained with 10 µg/ml bisbenzimide (Hoechst 33342) to analyze the number of nuclei.
Statistical Analyses
To compare the results using serum-starved versus cycling fibroblasts, we used the Fisher exact test (www.physics.csbsju.edu/stats/fisher.form.html). To compare the development of NT embryos derived from one cell population and oocytes from different sources, the percentage data per replication was arcsin-transformed and entered into SYSTAT, and multivariate general linear hypothesis was performed [23]. Fibroblast-clone and source of oocytes were the main effects. If a difference was detected, then the least significant difference program was invoked to determine where those differences existed.
RESULTS
In the first experiment, the feasibility of small cycling versus small serum-starved fibroblasts (same cell line, same passage number) for the use as donor karyoplasts was investigated. The fusion rate was similar for both groups (62% versus 58% for serum-starved and cycling cells). The use of serum-starved cells (G0) did not show a positive effect on the development of NT embryos in vitro, when compared with cycling cells (G1, Table 1).
|
For subsequent experiments, cycling fibroblast cells were used as donor karyoplasts. Four different clonal lines of transgenic fetal fibroblasts derived from the same fetus were fused to both sources of oocytes, and their development in vitro was investigated. Results of the in vitro development of NT embryos derived from the four cell lines using both oocyte sources are presented in Table 2.
|
The main effects of the model for each endpoint were clonal line and oocyte source. The cleavage rate was higher for sow oocytes than it was for gilt oocytes (P = 0.003). Development to the morula and blastocyst (P = 0.014) stages, or just to the blastocyst (P = 0.011) stage was also higher for sow oocytes than it was for gilt oocytes. In general, the proportion of embryos that developed to blastocysts was double when oocytes derived from sows were used as opposed to oocytes from gilts. There was no effect of oocyte source on the quality (number of nuclei) of blastocysts.
DISCUSSION
For our NT experiments, we decided to use "blind enucleation," which avoids the exposure of oocytes to bisbenzimide (Hoechst 33342) and UV light. In a previous study [24], it was shown that parthenogenetically activated porcine embryos showed lower quality when the oocytes were stained with Hoechst (without UV exposure). According to the findings in pigs, Dominko et al. [25] and Yassin et al. [26] found negative effects of bisbenzimide in combination with brief UV exposure on the development of bovine oocytes and embryos.
One important factor that is believed to influence the efficiency of NT is the cell cycle stage of the donor cell. Whereas some authors claim that the use of cells in G0 is required for complete reprogramming [3, 4], others used cycling donor cells in presumptive G1 and obtained offspring [12]. The cell cycle stage is a subject of debate, mainly because there is no system thus far that provides a 100% synchronization of cells in a certain stage of the cell cycle [27]. Therefore, the use of cells in a stage of the cell cycle other than the desired one cannot be excluded. In this study we investigated the development of porcine NT embryos derived from small serum-starved (presumptive G0) and cycling (presumptive G1) fetal fibroblast cells. In contrast to comparative studies in cattle [7, 28], in which the use of serum-starved donor cells resulted in better development, we found no effect of serum starvation on the in vitro development of porcine NT embryos.
Donor cells derived from preimplantation embryos [3, 29], fetal tissues [8, 11, 12], and adult tissues [4, 6, 9, 10, 30] have been used to generate live offspring. However, efficiencies varied with the use of different cell types [2, 10] and also with the use of different passage numbers [30]. In this report we investigated the feasibility of various clones derived from the same primary culture of fetal fibroblast cells for use in NT. Surprisingly, differences in the in vitro development of NT embryos were observed. Differences in the fusion rate between the cell lines used are mainly caused by differences in the size of the cells and also by their surface and membrane stability. Whereas in the cell line that resulted in the lowest fusion rates (F1-E5) the majority of cells showed a slightly rough surface, cells of line F1-D7 were bigger in size (14–16 µm versus 16–18 µm) and therefore resulted in higher fusion rates. It is interesting that no differences in fusion rates were observed when oocytes derived from sows were used. This may be due to differences in the surface structure of the plasma membrane between both oocyte sources. There is a possibility that the surface of sow oocytes is more homogenous, which thereby reduces the influence of the donor cell on the fusion rate.
Unfortunately, the limited number of cells did not allow an extensive characterization of the cell lines. However, a variation in the extent of chromatin methylation or histone acetylation may alter gene expression [31] and could therefore be (in part) responsible for differences in in vitro development after NT. Also, mutations or chromosomal abnormalities that cause reduced developmental ability for a certain clone cannot be excluded. Although it is unlikely in the case of a heterozygous modification, effects due to integration of the vector into the genome cannot be entirely excluded. Although the rate of blastocyst formation and average cell number varied between clonal lines, no characteristic, gross morphological differences were seen in blastocysts of similar cell number derived from different fibroblast clones. In a study in sheep, Wells et al. [29] compared the use of in vivo-matured versus in vitro-matured oocytes for use in NT. However, a factor that sometimes seems to be neglected or underestimated is the age of the cytoplast donor for NT experiments. We investigated the influence of the donor source for oocyte collection. For NT in pigs, the reason for using in vitro-matured oocytes ovaries derived mainly from gilts is primarily one of economics, and because sow ovaries are not available in most areas. However, a limited number of sow oocytes is commercially available. Therefore, we also investigated the development of NT embryos using oocytes from sows. In a preliminary experiment we compared the two maturation systems using the same oocyte source (gilts). After parthenogenetic activation no difference in the development to the blastocyst stage or in the nuclear numbers of blastocysts was found (data not shown). After NT, a significantly higher percentage of embryos developed to blastocysts when sow oocytes were used. In contrast, there was no effect of the oocyte source on the quality of blastocysts. We cannot exclude that sow oocytes may react differently to the maturation systems. There is a slight possibility that development is influenced by the oocyte source and the maturation medium. However, the data indicate that the use of cytoplasts from sow oocytes (in combination with the follicular fluid-containing maturation system) seems to be beneficial for use in NT.
In conclusion, this study suggests 1) that cells in presumptive G0 and cells in presumptive G1 are equally suitable for NT in pigs, and 2) that even within a cell line there are subpopulations of cells that are better suitable as donor karyoplasts for NT than others. To minimize the cost for recipient animals in attempts to produce cloned offspring it may therefore be helpful to culture subpopulations of various cell lines and store aliquots for further use. This will enable subpopulations to be investigated and selected for superior in vitro development before use in an NT embryo transfer scheme.
FOOTNOTES
First decision: 5 December 2000.
1 Supported by a grant from BioTransplant Inc., Charlestown, Massachusetts, and contribution 13089 from the Missouri Agricultural Experiment Station Journal Series. 
2 Correspondence: Randall S. Prather, Department of Animal Sciences, 162 Animal Science Research Center, University of Missouri-Columbia, Columbia, MO 65211. FAX: 573 882 6827; pratherr{at}missouri.edu
Accepted: January 18, 2001.
Received: October 30, 2000.
REFERENCES
This article has been cited by other articles:
|
|
 |
|
  Q. Zhou, S.H. Yang, C.H. Ding, X.C. He, Y.H. Xie, T.B. Hildebrandt, S.M. Mitalipov, X.H. Tang, D.P. Wolf, and W.Z. Ji A comparative approach to somatic cell nuclear transfer in the rhesus monkey Hum. Reprod., October 1, 2006; 21(10): 2564 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Lagutina, G. Lazzari, R. Duchi, S. Colleoni, N. Ponderato, P. Turini, G. Crotti, and C. Galli Somatic cell nuclear transfer in horses: effect of oocyte morphology, embryo reconstruction method and donor cell type Reproduction, October 1, 2005; 130(4): 559 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhu, J. A. Craig, P. W. Dyce, N. Sunnen, and J. Li Embryos Derived from Porcine Skin-Derived Stem Cells Exhibit Enhanced Preimplantation Development Biol Reprod, December 1, 2004; 71(6): 1890 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.M. Powell, N.C. Talbot, K.D. Wells, D.E. Kerr, V.G. Pursel, and R.J. Wall Cell Donor Influences Success of Producing Cattle by Somatic Cell Nuclear Transfer Biol Reprod, July 1, 2004; 71(1): 210 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hyun, G. Lee, D. Kim, H. Kim, S. Lee, D. Nam, Y. Jeong, S. Kim, S. Yeom, S. Kang, et al. Production of Nuclear Transfer-Derived Piglets Using Porcine Fetal Fibroblasts Transfected with the Enhanced Green Fluorescent Protein Biol Reprod, September 1, 2003; 69(3): 1060 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miyoshi, S. J. Rzucidlo, S. L. Pratt, and S. L. Stice Improvements in Cloning Efficiencies May Be Possible by Increasing Uniformity in Recipient Oocytes and Donor Cells Biol Reprod, April 1, 2003; 68(4): 1079 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Booth, D. Viuff, S. Tan, P. Holm, T. Greve, and H. Callesen Numerical Chromosome Errors in Day 7 Somatic Nuclear Transfer Bovine Blastocysts Biol Reprod, March 1, 2003; 68(3): 922 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Arat, J. Gibbons, S. J. Rzucidlo, D. S. Respess, M. Tumlin, and S. L. Stice In Vitro Development of Bovine Nuclear Transfer Embryos from Transgenic Clonal Lines of Adult and Fetal Fibroblast Cells of the Same Genotype Biol Reprod, June 1, 2002; 66(6): 1768 - 1774. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
